466
Participants
Start Date
May 31, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
November 30, 2014
Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321)
Macular Laser Photocoagulation
Laser therapy
Phoenix
Tucson
Arcadia
Beverly Hills
La Jolla
Mountain View
Oakland
Palm Desert
Sacramento
San Francisco
Santa Barbara
Torrance
Colorado Springs
Golden
New London
Fort Lauderdale
Fort Myers
Miami
Orlando
Winter Haven
Augusta
‘Aiea
Wichita
Portland
Baltimore
Boston
Missoula
Las Vegas
New Brunswick
Northfield
Teaneck
Lynbrook
Orchard Park
Rochester
Asheville
Charlotte
Raleigh
Portland
Kingston
Pittsburgh
Florence
West Columbia
Rapid City
Nashville
Abilene
Austin
Harlingen
Houston
San Antonio (2 Locations)
The Woodlands
Salt Lake City
Collaborators (1)
Bayer
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY